GlassScriptPhysician profile
Amanda Joy Mower
NPI 1730743378
$1,949.92
in general payments reported to CMS, 2019-2025
22 companies · $633 in 2025
The $633 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.74 · 2022: $275 · 2023: $472 · 2024: $490 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $319.88 | 2022-2025 | Aptima, Novasure, Acessa Provu System |
| Astellas Pharma US INC | $260.96 | 2023-2025 | Veozah |
| Organon LLC | $236.75 | 2021-2025 | Nexplanon |
| Biogen, INC. | $159.74 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $130.19 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $130.07 | 2023-2025 | |
| Abbvie INC. | $111.27 | 2021-2023 | |
| Exeltis, USA INC. | $93.80 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $90.13 | 2021-2025 | Paragard T 380a, Summit Doppler |
| Millicent US INC | $87.61 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Merck Sharp & Dohme LLC | $61.12 | 2021-2024 | Gardasil 9, Gardasil |
| Aspira Women'S Health INC | $60.39 | 2022-2025 | Ova1 |
| Dexcom, INC. | $38.65 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $28.89 | 2025 | Stratafix, Dermabond Prineo, Ethicon |
| Shield Therapeutics INC | $26.71 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.75 | 2023 | Wegovy |
| Mission Pharmacal Company | $16.68 | 2023 | Citranatal |
| Medicem INC. | $16.19 | 2023 | |
| Olympus America INC. | $16.09 | 2024 | Olympus |
| Myovant Sciences INC. | $15.81 | 2022 | |
| Avion Pharmaceuticals | $14.81 | 2023 | Balcoltra |
| Sage Therapeutics, LLC | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.